Dasha Y

PhD candidate, prostate cancer, Metzger lab @IGBMC @unistra

[Prostate Cell News @ProstateCell]

By combining single-cell and spatial transcriptomics, researchers reveal that prostatic tumors of mice with both Pten and Trp53 inactivation in #prostate luminal cells are hypoxic and progress within a complex immune microenvironment. | @cddpress

💡 https://t.co/9AL3lk8sHw

[Dasha Y @YanushkoD]

🚨paper alert 🚨 Our manuscript on targeting hypoxic signaling in metastatic and castration-resistant prostate cancer is out in @SpringerNature @cddpress Cell Death & Disease

https://t.co/FtK0273tP0

@ProstateCell

[GOFFIN Lab @GOFFINVincent2]

Pleased to share our recent open access publication in #EMBO Molecular Medicine showing that early eradication of #castration-tolerant #Club cells presents a promising therapeutic strategy to mitigate #prostatecancer progression towards #CRPC
👇
https://t.co/AilTe18Ipc

[Prostate Cell News @ProstateCell]

Early eradication of castration-tolerant Club-like cells presents a promising therapeutic strategy to mitigate prostate cancer progression toward #CRPC.

Get the full story in @EmboMolMed. #OpenAccess 📖

🔓 https://t.co/E83QLFXvEO

[Prostate Cell News @ProstateCell]

Dr. Sandrine Henri led this detailed characterization of immune cells in the healthy mouse #prostate.

The team discovered changes in the immune landscape associated with prostate cancer progression. #OncoImmunology

💡 Read about their findings: https://t.co/WmYh3NZQYu

[Dasha Y @YanushkoD]

See you tomorrow at the #EACR2025 poster session to discuss about hypoxia and myeloid cells in prostate cancer! @EACRnews

[Dasha Y @YanushkoD]

Je cours pour la @FondationARC le 8 mars 2026, vous pouvez soutenir ma course en faisant un don pour la recherche sur le cancer: https://t.co/rQg8TPUH6T

[Gabriel Malouf @GabrielMalouf]

Our latest study in @EmboMolMed reveals how TFE3 fusions drive oxidative metabolism and ferroptosis resistance in translocation renal cell carcinoma (tRCC). We define tRCC as a novel metabolic subtype of renal cancer. @IGBMC @unistra @srviswanathan
🔗https://t.co/v2unMxB9KO

[VIB Training & Conferences @VIBTrainConf]

Exciting news! The 3rd VIB Conference on Tumor Heterogeneity, Plasticity, & Therapy is coming up, Dec 10-12! During the 2 days of #THPT25, 21 top scientists will explore how tumor cells adapt, evolve, and resist therapies.
Don’t miss it! Info: https://t.co/gnrcuWs4GJ

#cancerbiology #cancertherapy
@vib_ccb

[Dasha Y @YanushkoD]

@CaP_pubs @ProstateCell

[Dasha Y @YanushkoD]

Extremely happy to share that a part of my PhD project just got published in Cell Death and Disease @cddpress https://t.co/uFlVDJIFfm
In this work, we uncover how prostate tumor microenvironment drives tumor cell plasticity.

[Dasha Y @YanushkoD]

Great time at the @crcl symposium! It was a real pleasure to present our work (available here https://t.co/jPGBTHXZ0Z) and to discuss. Thank you for such a warm welcome and for the poster prize by @FondationARC

[Dasha Y @YanushkoD]

@ClemLeMagnen @RobinDolgos Thank you Clem!

[Dasha Y @YanushkoD]

@gizemyayliv @cddpress Thank you!!

[Dasha Y @YanushkoD]

@locusbearico @cddpress grazie mille Pietro!

[Dasha Y @YanushkoD]

Thank you to @FRM_officiel for supporting the 4th year of my PhD, and @CNRSbiologie @Inserm @FondationARC @laliguecancer @IMC_Bio for supporting this project.

[Dasha Y @YanushkoD]

A great heartfelt thank you to the people who mentored and guided me through this project ( DM, @GillesLaverny and @BeatrizGerFalc ) and to our great collaborators @henri_sandrine @ClemLeMagnen @RobinDolgos

[Pietro Berico @locusbearico]

Finally out our work showing the specific inhibition of melanoma-lineage identity genes using a new generation of ecteinascidin. Kudos to @MCigrang, @JObid07 and the only one Frédéric Coin at @IGBMC !
https://t.co/uieWdk4AKl

[Dasha Y @YanushkoD]

@karraspan congrats! can’t wait to see your new findings!

[Prostate Cell News @ProstateCell]

Some great insight into the transcriptomic landscape of the prostate TME, led by Drs. @KiviahoAntti, @AUrbanucci, and @NykterLab.

Congratulations to the team! 🥳